Overview of Цефекон Н
| Property | Description |
|---|---|
| Active ingredient | Naproxen Sodium, Salicylamide, Caffeine |
| Form | Rectal Suppositories |
| Pharmacological class | Combined Analgesic-Antipyretic Agent |
| Common use | Symptomatic relief of pain and fever |
| Origin | Synthetic Derivatives |
Цефекон Н is defined as a synthetic, multicomponent analgesic and antipyretic combination designed for the general symptomatic relief of pain and accompanying febrile conditions. This preparation strategically integrates three distinct active substances to achieve a broad spectrum of relief, differentiating its action from medications that rely on a single ingredient. The formula is clinically recognized for its synergistic effect in pain management, particularly for acute, self-limiting discomfort.
Composition and Pharmaceutical Form
The medication is formulated with a precise combination of three active substances: Naproxen Sodium, Salicylamide, and Caffeine. Naproxen Sodium is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and provides analgesic and anti-inflammatory action by inhibiting cyclooxygenase enzymes. Salicylamide, a derivative of salicylic acid, primarily contributes potent antipyretic (fever-reducing) properties. The third ingredient, Caffeine, is a Central Nervous System (CNS) stimulant of the methylxanthine class, which acts to enhance or potentiate the analgesic effects of the other components. Цефекон Н is manufactured exclusively as a rectal suppository, a solid dosage form, differentiating it from common oral tablet forms, which is a key consideration when the oral route is problematic.
Rationale for the Triple-Component Formulation
The rationale for this combination lies in achieving multi-target symptomatic engagement, which is the unique feature of the Цефекон Н formulation compared to standard single-ingredient NSAID products. The three components—analgesic, antipyretic, and stimulant—work together to provide more comprehensive management of symptoms like a sudden-onset fever accompanied by general body aches. This blending of agents is intended to rapidly tackle the key symptoms of discomfort and elevated body temperature simultaneously, a capability that distinguishes it from simple combination products.
Regulatory References
